These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 19190958

  • 1. A randomized controlled clinical trial of citalopram versus fluoxetine in children and adolescents with obsessive-compulsive disorder (OCD).
    Alaghband-Rad J, Hakimshooshtary M.
    Eur Child Adolesc Psychiatry; 2009 Mar; 18(3):131-5. PubMed ID: 19190958
    [Abstract] [Full Text] [Related]

  • 2. Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder.
    Riddle MA, Scahill L, King RA, Hardin MT, Anderson GM, Ort SI, Smith JC, Leckman JF, Cohen DJ.
    J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1062-9. PubMed ID: 1429406
    [Abstract] [Full Text] [Related]

  • 3. Preschool children with obsessive-compulsive disorder and fluoxetine treatment.
    Ercan ES, Kandulu R, Akyol Ardic U.
    Eur Child Adolesc Psychiatry; 2012 Mar; 21(3):169-72. PubMed ID: 22271063
    [Abstract] [Full Text] [Related]

  • 4. Fluoxetine in acute treatment of children and adolescents with obsessive-compulsive disorder: a systematic review and meta-analysis.
    Maneeton N, Maneeton B, Karawekpanyawong N, Woottiluk P, Putthisri S, Srisurapanon M.
    Nord J Psychiatry; 2020 Oct; 74(7):461-469. PubMed ID: 32242450
    [Abstract] [Full Text] [Related]

  • 5. Citalopram for treatment-resistant obsessive-compulsive disorder.
    Pallanti S, Quercioli L, Paiva RS, Koran LM.
    Eur Psychiatry; 1999 Apr; 14(2):101-6. PubMed ID: 10572334
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Fluoxetine in children and adolescents with OCD: a placebo-controlled trial.
    Liebowitz MR, Turner SM, Piacentini J, Beidel DC, Clarvit SR, Davies SO, Graae F, Jaffer M, Lin SH, Sallee FR, Schmidt AB, Simpson HB.
    J Am Acad Child Adolesc Psychiatry; 2002 Dec; 41(12):1431-8. PubMed ID: 12447029
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. An open trial and discontinuation study of fluoxetine in children and adolescents with obsessive-compulsive disorder.
    Semerci ZB, Unal F.
    Turk J Pediatr; 2001 Dec; 43(4):323-8. PubMed ID: 11765163
    [Abstract] [Full Text] [Related]

  • 10. Sertraline and fluoxetine treatment of obsessive-compulsive disorder: results of a double-blind, 6-month treatment study.
    Bergeron R, Ravindran AV, Chaput Y, Goldner E, Swinson R, van Ameringen MA, Austin C, Hadrava V.
    J Clin Psychopharmacol; 2002 Apr; 22(2):148-54. PubMed ID: 11910259
    [Abstract] [Full Text] [Related]

  • 11. Citalopram intravenous infusion in resistant obsessive-compulsive disorder: an open trial.
    Pallanti S, Quercioli L, Koran LM.
    J Clin Psychiatry; 2002 Sep; 63(9):796-801. PubMed ID: 12363120
    [Abstract] [Full Text] [Related]

  • 12. Quality of life outcomes in patients with obsessive-compulsive disorder: relationship to treatment response and symptom relapse.
    Hollander E, Stein DJ, Fineberg NA, Marteau F, Legault M.
    J Clin Psychiatry; 2010 Jun; 71(6):784-92. PubMed ID: 20492845
    [Abstract] [Full Text] [Related]

  • 13. Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial.
    March JS, Biederman J, Wolkow R, Safferman A, Mardekian J, Cook EH, Cutler NR, Dominguez R, Ferguson J, Muller B, Riesenberg R, Rosenthal M, Sallee FR, Wagner KD, Steiner H.
    JAMA; 1998 Nov 25; 280(20):1752-6. PubMed ID: 9842950
    [Abstract] [Full Text] [Related]

  • 14. Response of symptom dimensions in obsessive-compulsive disorder to treatment with citalopram or placebo.
    Stein DJ, Andersen EW, Overo KF.
    Braz J Psychiatry; 2007 Dec 25; 29(4):303-7. PubMed ID: 18200396
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Obsessive-compulsive disorder: an open-label pilot trial of escitalopram.
    Galvão-de Almeida A, Quarantini LC, Góis CR, Santos-Jesus R, Miranda-Scippa AM, de Oliveira IR, da Silva Prado H, Leckman JF, Rosário MC.
    CNS Spectr; 2007 Jul 25; 12(7):519-24. PubMed ID: 17603402
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Double-blind study of dextroamphetamine versus caffeine augmentation for treatment-resistant obsessive-compulsive disorder.
    Koran LM, Aboujaoude E, Gamel NN.
    J Clin Psychiatry; 2009 Nov 25; 70(11):1530-5. PubMed ID: 19573497
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.